Should I buy Freshpet (FRPT) stock or is it too late?

Freshpet · Consumer Staples · price $73

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: JP Morgan — 57% of its targets hit on this sector (56 calls tested). It aims for $72 (-1.1 %), call made on July 29, 2026, maturing on July 29, 2027 (30 d ago).

The 1 reliable analyst $72-1.1 %

The 10 other firms $75+3.1 %

How to read it: the 1 reliable firms are not filtered by optimism — 0 aim above the price, 1 below, hence their $72 median. “The 10 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Freshpet

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
JP Morgan	80 %	+100.2 %	5	$72 -1%
Stifel	38 %	+10.9 %	16	$78 +7%
Piper Sandler	43 %	+9.9 %	7	$87 +20%
DA Davidson	50 %	+9.1 %	8	$95 +31%
Baird	46 %	+8.8 %	13	$75 +3%
Benchmark	36 %	-4.6 %	11	$93 +28%
Oppenheimer	18 %	-18.9 %	11	$80 +10%
Truist Securities	12 %	-25.8 %	8	$50 -31%

In short — Should you invest in Freshpet? Is it too late, still worth it? Analysts are fairly positive (64% buy, median target $72, i.e. -1%). But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

64% of analysts rate it a buy (Buy consensus, 11 ratings) — a sign of market conviction.

⚠️ Reasons to hesitate

Even the most reliable firm on FRPT, UBS (100% hit rate, 2 scored calls), only targets $48 (call made on September 8, 2025, maturing on September 8, 2026) (-34%) in its most recent call. The stock may already have run past its target.
The consensus is not unanimous: of 11 ratings, 4 are neutral.
Limited upside: the median target is only -1% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on FRPT

Median target $72 (-1%) · 11 ratings · Buy consensus

Strong Buy00%

Buy764%

Hold436%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Freshpet now?

We won't decide for you. The facts: 64% of analysts rate it a buy, median target $72 (-1%), and UBS (most reliable on FRPT, 100%) targets $48. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Freshpet?

The stated upside is small: the median target ($72) sits just -1% from the price ($73) (most reliable on FRPT: UBS, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Freshpet still worth investing in?

It depends on the gap between the price ($73) and its estimated value: analysts target $72 on median (-1%), with 64% buys (most reliable on FRPT: UBS, 100%). Cross-check with their real reliability on FRPT and the cautions above. Information, not advice.

What's the main risk in buying FRPT?

Even the most reliable firm on FRPT, UBS (100% hit rate, 2 scored calls), only targets $48 (call made on September 8, 2025, maturing on September 8, 2026) (-34%) in its most recent call. The stock may already have run past its target.

→ Go deeper: the full Freshpet profile (consensus, analyst reliability, price target, performance).